These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
363 related items for PubMed ID: 37298132
1. Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications. Dziadkowiak E, Nowakowska-Kotas M, Rałowska-Gmoch W, Budrewicz S, Koszewicz M. Int J Mol Sci; 2023 May 24; 24(11):. PubMed ID: 37298132 [Abstract] [Full Text] [Related]
3. Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies. Collet R, Caballero-Ávila M, Querol L. Rev Neurol (Paris); 2023 Oct 11; 179(8):831-843. PubMed ID: 36907709 [Abstract] [Full Text] [Related]
4. Immune-Mediated Neuropathies. Gwathmey KG, Smith AG. Neurol Clin; 2020 Aug 11; 38(3):711-735. PubMed ID: 32703478 [Abstract] [Full Text] [Related]
5. [Immune-mediated neuropathies]. Stoll G, Reiners K. Nervenarzt; 2016 Aug 11; 87(8):887-98. PubMed ID: 27474733 [Abstract] [Full Text] [Related]
6. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies. Lehmann HC, Hartung HP. J Neuroimmunol; 2011 Feb 11; 231(1-2):61-9. PubMed ID: 21056913 [Abstract] [Full Text] [Related]
7. Treatment of immune-mediated inflammatory neuropathies. Hadden RD, Hughes RA. Curr Opin Neurol; 1999 Oct 11; 12(5):573-9. PubMed ID: 10590894 [Abstract] [Full Text] [Related]
8. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients. Busby M, Donaghy M. J Neurol; 2003 Jun 11; 250(6):714-24. PubMed ID: 12796835 [Abstract] [Full Text] [Related]
9. Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP. Querol L, Lleixà C. Neurotherapeutics; 2021 Oct 11; 18(4):2222-2235. PubMed ID: 34549385 [Abstract] [Full Text] [Related]
10. Treatment of immune-mediated, dysimmune neuropathies. Finsterer J. Acta Neurol Scand; 2005 Aug 11; 112(2):115-25. PubMed ID: 16008538 [Abstract] [Full Text] [Related]
11. Treatment of immune neuropathies. Van Doorn PA, Garssen MP. Curr Opin Neurol; 2002 Oct 11; 15(5):623-31. PubMed ID: 12352007 [Abstract] [Full Text] [Related]
12. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification. Eldar AH, Chapman J. Autoimmun Rev; 2014 Oct 11; 13(4-5):525-30. PubMed ID: 24434363 [Abstract] [Full Text] [Related]
13. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies. Latov N. Nat Rev Neurol; 2014 Aug 11; 10(8):435-46. PubMed ID: 24980070 [Abstract] [Full Text] [Related]
14. Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Lindenbaum Y, Kissel JT, Mendell JR. Neurol Clin; 2001 Feb 11; 19(1):187-204. PubMed ID: 11471764 [Abstract] [Full Text] [Related]
15. [Recent acquisitions in the treatment of chronic immune-mediated polyneuropathies]. Léger JM, Viala K. Rev Neurol (Paris); 2004 Feb 11; 160(2):205-10. PubMed ID: 15034478 [Abstract] [Full Text] [Related]
16. Autoantibodies in immune-mediated inflammatory neuropathies. Martín-Aguilar L, Pascual-Goñi E, Querol L. Med Clin (Barc); 2019 Nov 15; 153(9):360-367. PubMed ID: 31443948 [Abstract] [Full Text] [Related]